Behavioural Intervention
Exercise Therapy for Adenomatous Polyposis
Recruiting1 award8 criteria
Ann Arbor, Michigan
"This trial is looking at exercise therapy, specifically aerobic exercise therapy involving treadmill walking. The main goal is to determine the best level of exercise therapy for further testing in larger trials. The study will involve a
Popular Filters
Trials for Adenomatous Polyposis Patients
Dietary Supplement
BHB Supplements for Adenomatous Polyposis
Recruiting0 awards2 criteria
Philadelphia, Pennsylvania
This trial aims to see if taking BHB supplements can help prevent the growth of intestinal adenomas in people with FAP. If successful, this could reduce the need for frequent medical procedures and possibly prevent
REC-4881 for Familial Adenomatous Polyposis
Recruiting0 awardsPhase 1 & 2
Marrero, Louisiana
This trial is testing a new drug called REC-4881 in people with Familial Adenomatous Polyposis (FAP). The goal is to see if the drug can reduce or slow the growth of polyps in their intestines, making the condition easier to manage and potentially avoiding more surgeries.
Trials for APC Positive Patients
Dietary Supplement
BHB Supplements for Adenomatous Polyposis
Recruiting0 awards2 criteria
Philadelphia, Pennsylvania
This trial aims to see if taking BHB supplements can help prevent the growth of intestinal adenomas in people with FAP. If successful, this could reduce the need for frequent medical procedures and possibly prevent
REC-4881 for Familial Adenomatous Polyposis
Recruiting0 awardsPhase 1 & 2
Marrero, Louisiana
This trial is testing a new drug called REC-4881 in people with Familial Adenomatous Polyposis (FAP). The goal is to see if the drug can reduce or slow the growth of polyps in their intestines, making the condition easier to manage and potentially avoiding more surgeries.
Trials With No Placebo
mTOR Inhibitor
eRapa for Adenomatous Polyposis
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial tests Encapsulated Rapamycin (eRapa) taken by mouth to help patients with Familial Adenomatous Polyposis (FAP) reduce the number of polyps in their colon. The medication works by slowing down cell growth, aiming to manage this genetic condition more effectively. Rapamycin has shown potential in early research for preventing the development of polyps in FAP.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.